...
首页> 外文期刊>The American Journal of Gastroenterology >Endoscopic resection for Barrett's high-grade dysplasia and early esophageal adenocarcinoma: an essential staging procedure with long-term therapeutic benefit.
【24h】

Endoscopic resection for Barrett's high-grade dysplasia and early esophageal adenocarcinoma: an essential staging procedure with long-term therapeutic benefit.

机译:内镜切除术治疗巴雷特氏高度不典型增生和早期食管腺癌:具有长期治疗益处的重要分期程序。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVES: Patients with Barrett's high-grade dysplasia (HGD) or early esophageal adenocarcinoma (EAC) that is shown on biopsy alone continue to undergo esophagectomy without more definitive histological staging. Endoscopic resection (ER) may provide more accurate histological grading and local tumor (T) staging, definitive therapy, and complete Barrett's excision (CBE); however, long-term outcome data are limited. Our objective was to demonstrate the effect on histological grade or local T stage, efficacy, safety and long-term outcome of ER for Barrett's HGD/EAC and of CBE in suitable patients. METHODS: This prospective study at two Australian academic hospitals involved 75 consecutive patients over 7 years undergoing ER for biopsy-proven HGD or EAC, using multiband mucosectomy or cap technique. In addition, CBE by 2-3-stage radical mucosectomy was attempted for all Barrett's segments
机译:目的:仅在活检中显示的Barrett高度不典型增生(HGD)或早期食道腺癌(EAC)患者继续行食管切除术,而没有明确的组织学分期。内窥镜切除术(ER)可提供更准确的组织学分级和局部肿瘤(T)分期,确定性治疗以及完整的巴雷特切除术(CBE);但是,长期结果数据有限。我们的目的是证明合适的患者对Barrett HGD / EAC和CBE对ER的组织学分级或局部T期,疗效,安全性和长期预后的影响。方法:这项前瞻性研究在两家澳大利亚学术医院进行,涉及7名连续7年以上的75例接受ER活检的HGD或EAC患者,采用多波段粘膜切除术或冠状动脉技术。此外,对于年龄小于75岁且合并症极少的患者,尝试对所有Barrett部段<或= 3 cm的患者进行2-3期根治性黏膜切除术的CBE。结果:活检组织学检查显示89%的患者为HGD,11%为EAC。但是,ER的组织学改变了48%的患者的分级或分期(下降28%,上升20%),其中HGD为53%,低度异型增生(LGD)为19%,粘膜腺癌为13%,粘膜下腺癌9%的患者没有异常,4%的患者没有异常发育。 CBE成功率为94%。并发症是一种愿望(住院治疗,完全康复),在内窥镜下成功扩张了六个狭窄。在平均随访31个月(范围3-89)中,ER部位无复发,11%发生了异时病变,有5例因ER表现为粘膜下浸润而接受了食管切除术。食管切除术标本中有3例为T0N0M0,2例为T1N0M0。没有因腺癌而死亡。结论:ER通过提供安全有效的治疗方法改变了48%的患者的组织学分级或局部T分期,并显着降低了食管切除率。在短段巴雷特食管中,ER对CBE的成功率很高(94%)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号